Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) agonists such as pioglitazone restore fatty acid oxidation and mitochondrial homeostasis, improving right ventricular function in PAH models [52]. This evidence concerns the gene PPARG and pulmonary arterial hypertension.